INS and metabolic dysfunction-associated steatotic liver disease: Emerging evidences have indicated that ketogenic diet may be a potential therapeutic strategy for metabolic disorders including epilepsy, type 2 diabetes, obesity, nonalcoholic fatty liver disease, PCOS as well as cancers through reduction of blood glucose and insulin levels, improving insulin sensitivity and regulation of glucose and fat metabolism [120, 121].